Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson’s Disease
Open Access
- 28 July 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 10 (3) , 819-830
Abstract
It was recently shown (Sampson et al., Elife 9 , 2020) that an amyloidogenic protein, CsgA, present in E. coli biofilms in the gut can trigger Parkinson’s disease in mice. This study emphasizes the possible role of the gut microbiome in modulation (aKeywords
This publication has 95 references indexed in Scilit:
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in NeuronsCell, 2013
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic micePrion, 2012
- Macromolecular Crowding Tunes Folding Landscape of Parallel α/β Protein, ApoflavodoxinJournal of the American Chemical Society, 2010
- The Molecular Basis of Functional Bacterial Amyloid Polymerization and NucleationJournal of Biological Chemistry, 2008
- Neuropathology, biochemistry, and biophysics of α‐synuclein aggregationJournal of Neurochemistry, 2007
- Amyloidogenic potential of foie grasProceedings of the National Academy of Sciences, 2007
- Amyloid Fibril Formation of α-Synuclein Is Accelerated by Preformed Amyloid Seeds of Other ProteinsJournal of Biological Chemistry, 2005
- Conformational properties of α-synuclein in its free and lipid-associated states 1 1Edited by P. E. WrightJournal of Molecular Biology, 2001
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997